It is not recommended to administer routine pre-treatment with a P2Y12 receptor inhibitor to patients in whom the coronary anatomy is not known and early invasive management is planned
It is not recommended to administer routine pre-treatment with a P2Y12 receptor inhibitor to patients in whom the coronary anatomy is not known and early invasive management is planned